Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial Meeting Abstract


Authors: Oh, D. Y.; Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Reinacher-Schick, A.; Tortora, G.; Algül, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Schlienger, K.; Locker, G. Y.; Kindler, H. L.
Abstract Title: Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Meeting Title: 2019 ESMO Asia Congress
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 9
Meeting Dates: 2019 Nov 22-24
Meeting Location: Singapore
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-11-01
Start Page: mdz422.004
Language: English
ACCESSION: WOS:000503487700123
PROVIDER: wos
DOI: 10.1093/annonc/mdz422.004
Notes: Meeting Abstract: 126O -- Appears on pages ix44-ix45 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly